Stockreport

Cartesian Therapeutics Announces New Employment Inducement Grant

Cartesian Therapeutics, Inc.  (RNAC) 
PDF GAITHERSBURG, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mR [Read more]